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Abstract
Kirby, Jeannette. MPH. The University of Memphis. December, 2012. Predictors of
wait-time for antibiotic initiation and its association with length of hospital stay and ICUadmission among children with cancer at the Southern Philippine Medical Center. Major
Professor: Vikki G. Nolan.
A window of one hour or less from start of signs and symptoms of infection to
antibiotic administration (AWT) is considered good clinical practice in developed
countries, but less feasible in resource poor countries. This study aimed to identify
predictors of AWT and studied its association with hospital length of stay (LOS) and
intensive care unit (ICU) admission. A survey of healthcare providers assessed quality of
care associated with the institutional capacity and response. AWT averaged four days
with patient status being the only predictor upon multivariate analysis. For predictors
associated with outcomes, parental education and patient status were associated with LOS
and absolute neutrophil count (ANC) and AWT were found to be significant predictors
for ICU admission.
Only 59% of nurses recognized fever as an oncologic emergency and perception
of antibiotics availability varied among nurses, physicians and pharmacists. Modification
of predictors may reduce AWT assuring better outcome and survival.
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Introduction
Infections in patients undergoing cancer treatment are considered a medical
emergency (Wicki et al., 2008). Neutropenic febrile patients can rapidly progress to
septic shock if the administration of empiric broad-spectrum antibiotic therapy is delayed
by more than 1-hour upon suspicion of sepsis (Dellinger et al., 2008; W. T. Hughes et al.,
2002). In the Philippines, as in other low- and middle-income countries, childhood
cancer treatment is deficient and results in lower survival (Ribeiro et al., 2008). This
stands in contrast with developed countries where long-term survival is as high as 80%
for children with cancer (Eden, 2011). Applying the cancer incidence rate obtained from
cancer registries in developed countries (Steliarova-Foucher et al., 2004) to the almost 33
million children aged 17 or less living in the Philippines (Report, 2001), 4,600 children
per year are estimated to develop cancer in the Philippines.
For the small number of Philippine children who are diagnosed and treated (Eden,
2011), treatment success and survival is dependent on speedy medical intervention should
oncologic emergencies like infectious episodes (Ammann, Hirt, Lüthy, & Aebi, 2004),
bleeding (Dellinger et al., 2008) and/or adverse events secondary to chemotherapy
(Tamburro, 2005) arise. Treatment induced neutropenia increases susceptibility to
infection in relation to the intensity of chemotherapy by reducing absolute neutrophil
count (ANC) through mylosuppression (Ammann et al., 2004; Wicki et al., 2008). Risk
of infection therefore is inversely related to ANC making ANC an indicator of potential
severity, duration, and speed of infection (W. T. Hughes et al., 2002). For patients
undergoing chemotherapy, the risk for infection is ubiquitous. Catheter-associated
bloodstream infections (CABSI) account for 73% of cases of bacteremia in pediatric
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cancer patients (Srinivasan et al., 2010). Opportunistic infections are another source of
danger, as cytotoxic agents cause the loss of epithelial mucosal cells in the
gastrointestinal, sinopulmonary, and genitourinary tract, allowing local flora such as
coliforms, streptococci, Pseudomonas aeruginosa, and Candida to penetrate the
bloodstream (Pizzo, Rubin, Freifeld, & Walsh, 1991). The environmental setting of a
patient with profound and/or prolonged neutropenia can therefore play an important role
in the increased risk for infection. A prospective study of 139 patients for example found
that inpatients were 7 times more likely to develop CABSI (p < .0001) as compared to
outpatients (Allen et al., 2008). Apart from the hospital environment, however, immunecompromised patients are also at risk for such infections as community acquired
pneumonia and community acquired bacteremia with Staphylococcus being the most
common etiologic pathogen (Watson et al., 2003). Infection control, therefore, is
essential. Empiric broad-spectrum antibiotic therapy is imperative upon the first sign of
fever since fever may be the first symptom of bacterial infection (Wicki et al., 2008) and
determining the cause of infection through blood cultures takes time (Burry et al., 2012).
Also antibiotic-resistant microorganisms associated with frequent hospitalization and/or a
history of prior infections can increase the risk for severe infection or sepsis (Ammerlaan
et al., 2009; Srinivasan et al., 2010). Gram-negative methicillin-resistant bacteria for
instance has required in 18.2% of cases a change in antimicrobial therapy (Iregui, Ward,
Sherman, Fraser, & Kollef, 2002).
Prompt antimicrobial administration is therefore especially important to
increase survival in immune-compromised patients for one study showed, that a delay of
antibiotic therapy in excess of 6 hours is associated with an 8 times higher risk of death
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from bacterial meningitis in non-immune compromised patients (Proulx, Frechette, Toye,
Chan, & Kravcik, 2005). In children with cancer, infectious processes may initiate at
home or in the healthcare institution during cancer treatment. Factors therefore
associated with both segments of the patient care support chain that include the „access‟
and the „institutional‟ components determine the speed of medical service delivery.
Educated caregivers for instance are instrumental as part of the patients‟ home
environment to expedite the arrival of the patient to the hospital for examination and
treatment (Montoya, L, 2011). In the hospital setting on the other hand, institutional work
flow can impact the speed of medical service delivery with delineated processes that
facilitate teamwork (Lau et al., 2010) and with appropriate staffing that determines the
work load of available healthcare personnel (Needleman, Buerhaus, Mattke, Stewart, &
Zelevinsky, 2002). At St. Jude Children‟s Research Hospital (SJCRH), policies are in
place to minimize the interval between onset of signs and symptoms and the
administration of antibiotics (AWT), with the aim of limiting the wait-time to less than
one hour. In nations with limited resources, however, few studies have assessed AWT. A
pilot study at the St. Jude partner site in Guatemala (Unidad National de Oncologia
Pediatrica, Guatemala City) showed a mean wait-time of 86.1 minutes (range, 50 minutes
to 3 hours and 35 minutes) (Perry, E, 2010). The wait-time in this study however was
defined as the time elapsed between the ordering and administration of antibiotics and
was longer than the suggested one hour interval for this small sample size of 9 patients.
This finding indicates that further studies are needed.
We hypothesize that socio-economic status of caregivers and inadequate
institutional resources are predictors of AWT and make AWT a risk factor for poorer
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outcomes in the care of children with cancer by increasing ICU admission, hospital
length of stay and death, at the Southern Philippine Medical Center (SPMC). For the past
2 years, the Infectious Diseases Initiative - International Outreach Division (ID-IO) has
been building human capacity for better care and prevention of infections at this SJCRH
pediatric cancer partner site. This effort includes the implementation of standards of good
care for pediatric oncology services that entails recording the time of onset of sign and
symptoms, arrival of patient at the hospital, and the first dose of antibiotic given. The
purpose of this study is to identify predictors that prolong AWT in these pediatric cancer
patients and to study its association with length of hospital stay (LOS) and intensive care
unit (ICU) admission. Wait-time for treatment of febrile events, LOS and rate of ICU
admission among pediatric cancer patients may be reduced if predictors of wait-time can
be identified and addressed.
Methods
Study Design
The study was a single site, retrospective, chart review, and a cross-sectional
survey of healthcare providers conducted at the Children‟s Cancer and Blood Disease
Unit (CCBDU) of the Southern Philippine Medical Center (SPMC). This study was
approved by the Institutional Review Boards (IRB) of SJCRH, the SPMC, and the
University of Memphis.
Study Subjects
Patients. Eligible subjects were children ≤ 18 years of age, who received at least
one dose of antibiotics for suspected infection, between January 1, 2011 and June 30,
2011. This sample was identified from the list of patients on the monthly
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admission/discharge report of the CCBDU, and verified against the monthly pediatric
infection control reports of the CCBDU.
Health care providers. Healthcare providers, who had either direct or indirect
contact with patients, and had consented in writing to be interviewed, were eligible for
inclusion.
Setting
The SPMC is a tertiary care facility located on the island of Mindanao, in the city of
Davao. The study was conducted at the CCBDU that consists of 25 beds as part of a 200
bed pediatric ward. The unit treats approximately 160 patients per year, with about 40
inpatient stays per month. It has one full-time infection preventionist and one infection
specialist available for consultation when needed. Specialized care, available only during
weekday mornings, is provided by a pediatric oncologist, and two hematologists;
afternoons, nights, and weekends are staffed by pediatric residents and medical students.
Because over 60% of patients come from the surrounding rural countryside, family
lodging is available at the “House of Hope”, which can accommodate 21 occupants.
Data Collection
We collected information to determine AWT. AWT is defined as the length of time
from the onset of signs and symptoms of infection to the first dose of antibiotic given.
AWT is also the aggregate of two components of the patient care support chain, namely
„access‟ wait-time, measured as the time interval from onset of signs and symptoms to
hospital admission, and „institutional‟ wait-time, measured as the time interval from
admission to the hospital to the first dose of antibiotic given. The primary data source
was the case report form (CRF) which captured these data from patients‟ medical records.
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The CRF captured patient/caregiver characteristics that may be associated with AWT
such as age and gender; patient status variables such as established and referred status.
Also captured were socio-economic variables such as insurance coverage, house
ownership, residential electricity, number of siblings, family income and parental
education. Also, events occurring during hospitalization and hospital course such as date
and time of admission, antibiotic administration, ICU admission, hospital discharge and
death were ascertained. In addition, the Pediatric Oncology Network Database served as
a secondary source complementing or verifying required data. This electronic data
repository platform is supported by SJCRH and used by most of its international partner
sites including the CCBDU at the SPMC
An interviewer-administered questionnaire was used to collect data about
institutional and personnel factors that may affect the wait-time during the patient‟s
hospitalization. Institutional healthcare delivery was assessed by a 32-item questionnaire
administered to healthcare providers and was tailored to the professional category of the
participants.
The questionnaire evaluated institutional human resources such as nurses,
physicians, pharmacists and laboratory technicians; non-human resources such as
medical supplies, diagnostic devices, and medications; and institutional standards of care
practices that include knowledge of personnel regarding medical infectious emergencies,
treatment guidelines, and infection care and triage procedure. It assessed healthcare
provider staffing, availability of supplies, and best-care practices. The questionnaire
used a Likert-like scale with four ratings of “Most of the time (> 90% of the time)”,
“Sometimes (< 50% of the time)”, “Rarely (< 10% of the time)” and “Never” in order to
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assess response time and knowledge of febrile emergencies, triage-procedures, and
initiation of antibiotic therapy. Perceived availability of medical supplies and antibiotics
was also assessed using this scale. Free-form questions determined length of employment
and workload.
Predictors of AWT
Patient related variables. Possible predictors included demographic information
such as sex and age, patient status (established patient, currently treated at the CCBDU,
or new patient), and whether the patient has been referred from a private physician or
another medical facility, and patient‟s diagnosis. Patients were grouped into two
diagnostic categories: hematologic malignancies, which included acute lymphocytic
leukemia (ALL), acute myelogenous leukemia (AML) and lymphomas, and other tumors.
Patients‟ ANC were categorized as ≤ 500, > 500 or unknown. ANC ≤ 500 reflects low
immune function with a propensity for infections (W. T. Hughes et al., 2002; Pizzo et al.,
1991).
Caregiver related variables. Data were collected on socio-economic factors that
may impact AWT. Caregivers‟ insurance coverage, house ownership, availability of
residential electricity and family support, in form of economic assistance, were
categorized into „yes‟, „no‟ or „unknown‟. Household income, level of parental education,
and the number of patients‟ siblings was also collected. At the SPMC, patients were
classified into three levels of household income: those making up to 3,000 pesos per
month were classified as poor, those making between 3,000 and 10,000 pesos per month,
medium income, and those making more than 10,000 pesos per month were classified as
wealthy. Parental education was also categorized into three levels: up to 8 years of
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education, nine to 12 years of education, or more than 12 years of education. Number of
siblings was dichotomized at the sample median, two siblings or fewer versus three or
more siblings. Finally physical access to health care, such as cost of transportation and
time and distance travelled, was assessed as continuous variables.
Outcomes
We studied the association between wait-time and admission to the intensive
care unit (ICU), hospital length of stay (LOS) and death.
Statistical Analysis
Descriptive Statistic. Frequencies were generated for all categorical variables
and the mean, standard deviation, median, and range were determined for all continuous
variables. The association between AWT and categorical variables was assessed using
two-sample independent t-tests. The association between AWT and continuous variables
was assessed using Pearson‟s correlation coefficients
Cox proportional hazards regression analysis was used to estimate bivariate and
multivariate associations of AWT. Hazard ratios (HR), 95% confidence intervals (95%
CI), and p values were determined. A backwards method selection was used to identify
the best multivariate model; all variables were entered into the regression model and
removed one at a time using an upper limit of significance of .15. The access and
„institutional‟ wait-time segments were analyzed individually using the same method
described above.
Next, we studied the association between AWT and LOS and ICU admission.
LOS was analyzed using Cox proportional hazard models using the same methods used
to study wait-time. To determine the association between ICU admission and AWT, a
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logistic regression model was used. A backward selection method was used to determine
the final model using an upper limit of significance of .15 for removal of predictors.
Responses to the survey questions were described and are presented as frequency and
percent of the total. All analyses were performed using SAS version 9.3 (SAS Institute,
2011).
Results
Descriptive Statistics
Patient sample. One hundred twenty-eight admissions met the eligibility
requirements. Six admissions were excluded because the date and/or time of onset of
signs and symptoms were missing. Twenty-one patients with non-malignant blood
disorders were excluded because their pathology was clinically different from the
pediatric cancer population. Diagnosis was missing for three patients, and one admission
was deemed to be an outlier because the reported AWT was not clinically feasible (90
days), leaving 97 admissions (76%) included in the analyses. Fifty-four percent were
male (n = 52), and the mean age was 6.8 years ranging from 14 days - 17.8 years.
Seventy-four percent of patients (n = 72) were known patients, and 25% were referred
patients (n = 24). Hematologic malignancies were more common than other tumors (61%
vs. 39%). Twenty-seven percent (n = 26) had an ANC of 500/µL or less, 61% (n = 59)
greater than 500/µL, and 12% (n = 12) were unknown (see Table 1).
Seventy percent (n = 68) had insurance coverage, 36% (n = 35) were home
owners, 44% (n = 43) had residential electricity, and 41% (n = 40) indicated that they
received financial and economic support from their family. Fifty-three percent (n = 51) of
the families were poor, 26% (n = 25) had medium income and 8% (n = 8) were wealthy.
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Fourteen percent (n = 14) of parents had eight years or less of formal education, 37% (n =
36) attained between nine to 12 years of education, and 23% (n = 22) had college level
education (> 12 years); 26% (n = 25) were missing. The majority of patients 46% (n =
45) had one or two siblings and 34% (n = 33) had three or more siblings; 20% (n = 19) of
patients were missing sibling information.
The mean AWT was 4.0 days, ranging from zero hours to 28 days. The mean
„access‟ wait-time was 3.3 days ranging from zero hours to 28 days and the mean
„institutional‟ wait-time was 0.8 days ranging from zero hours to 4.5 days. Eighteen
percent (n = 17) of the patients were admitted to the ICU, and 4% (n = 4) of the patients
died. Surviving patients were discharged after an average LOS of 13.0 days, ranging from
9 hours to 40.0 days (see Table 1).
We found a significant association between patient status and AWT. Established
and non-referred patients differed significantly from new and referred patients (p = .018
and p = .042, respectively; see Table 2). Crude analyses of AWT showed that known
patients received antibiotics on average two times faster than new patients (HR = 2.17,
95% CI: 1.30 - 3.60; p = .003, see Table 3).
Crude (bivariate) analysis of the component of „access‟ showed the same
predictor indicating that known patients received antibiotics on average two times faster
than new patients (HR = 2.11, 95% CI: 1.35 - 3.32; p = .001). Crude analysis of
„institutional‟ wait-time identified no significant predictors (see Table 4). Crude analysis
showed that diagnosis, family income, patient status and parental education were
predictors of LOS. Children with parents who had more than 12 years of formal
education were discharged from the hospital two times faster than children of parents
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with eight years of education or less (HR = 2.08, 95% CI: 1.15 - 3.75; p = .015), and
known patients were discharge 54% faster than new patients (HR = 1.54, 95% CI: 1.08 2.20; p = .017). Patients with hematologic malignancies were discharged 67% faster than
patients diagnosed with other tumors (HR = 1.67, 95% CI: 1.09 - 2.55; p = .017), and
patients with unknown household income were discharged significantly faster than
patients of high household income (HR = 2.66, 95% CI: 1.22 - 5.79; p = .014, see Table
5).
Table 6 shows determinants of ICU admission. Analyses showed that diagnosis
and ANC count were significant predictors of ICU admission. Patients with hematologic
malignancies were six times more likely to be admitted to ICU than patients with other
tumors (OR = 6.14, 95% CI: 1.32 - 28.62; p = .021). Patients with unknown ANC and
patients with ANC count of 500/µL or less had almost 10 and six times the odds to be
admitted to ICU as compared to patients with an ANC count of greater than 500/µL (OR
= 9.82, 95% CI: 2.12 - 45.45; p = .004 and OR = 6.11, 95% CI: 1.64 - 22.71; p = .007,
respectively).
Multivariate analyses did not identify any additional predictors. Because of
collinearity between known versus unknown and referred versus non-referred patients,
only known patients (Yes/No) was included in the multivariate analyses. Only patient
status was a significant predictor of AWT and „access‟ wait-time. Multivariate analyses
of the institutional component identified family income, parental education, age, and
insurance coverage as significant predictors of wait-time. Poor patients had a 55% longer
wait-time to antibiotic administration than patients from high-income households (HR =
0.45, 95% CI: 0.21- 0.95; p = .037). Patients with unknown income experienced a 64%
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longer wait-time to antibiotic administration than patients of high income households
(HR = 0.36, 95% CI: 0.16 - 0.80; p = .012). Parental education was significant for
patients with unknown parental education level; they were found to have a 77% longer
wait-time (HR = 0.23, 95% CI: 0.08 - 0.61; p = .003) than patients whose parents had
eight years or less of formal education. In addition, for every increase in one year of age,
„institutional‟ wait-time decreased by 6% (HR = 1.06 - 95% CI: 1.01 - 1.11; p = .021).
Patients with unknown insurance coverage received antibiotics almost four time faster
than patients who had no insurance coverage (HR = 3.83, 95% CI: 1.39 - 10.57; p = .010,
see Table 4).
Upon Multivariate analysis predictors of LOS were family income, patient status
of known vs. new patient and parental education. Multivariate analyses showed that
known patients were discharged two times faster than new patients (HR = 2.07, 95% CI:
1.40 - 3.07; p < .001) and children of parents with more than 12 years of formal education
were discharged over three times faster than children of parents with eight years or less of
education (HR = 3.22, 95% CI: 1.54 - 6.71; p = .002). Children with unknown family
income were discharged more than three times faster than children with high household
income (HR = 3.46, 95% CI: 1.37 - 8.74; p = .009, see Table 5). Patients with unknown
ANC count and ANC counts of 500/µL or less were 11 and six times more likely to be
admitted to the ICU (OR = 11.40, 95% CI: 2.26 - 57.52; p = .003 and OR = 6.02, 95%
CI: 1.50 - 24.11; p = .011, respectively). AWT was also a predictor for ICU admission.
The odds of ICU admission increased 12% for every one day increase in AWT (OR =
1.12, 95% CI: 1.00 - 1.25; p = .043).
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„Institutional‟ wait-time for antibiotic administration is a marker of the quality of
patient care in healthcare settings. It is affected by healthcare provider workload,
knowledge, and adherence to institutional standard-of-care-practices. Thirty-six
healthcare providers participated in a cross-sectional survey. Forty-seven percent were
nurses (n = 17), 31% were pharmacists (n = 11), 14% were physicians (n = 5) and 8%
were laboratory technicians (n = 3). The mean time of employment for all healthcare
providers was 4.2 years ranging from 2.2 days to 39.0 years. Pharmacists and laboratory
technicians have the longest mean time of employment of 5.1 years (range, 8 months 18.0 years) and 18.7 years (range, 3.0 - 39.0 years), respectively. Nurses and physicians
have the shortest mean time of employment averaging 1.4 years (range, 2 days - 4.0
years) and 2.9 years (range, 7 months - 9.0 years), respectively. Physicians see on
average 30.1 (range, 20.0 - 50.0) patients per day, nurses attend to 19.8 (range, 6.0 - 25.0)
patients a day, pharmacists fill on average 217.3 (range, 100.0 - 300.0) prescriptions a
day and technicians test on average 20.0 blood cultures a day (see Table 7).
The survey indicates that, while 100% nursing staff recognized bleeding and
unstable vital signs as an oncologic emergency and responded promptly by informing the
attending physician in less than 15 minutes, only 59% (n = 10) gave the same importance
to fever greater than 38o C. In comparison, symptoms of vomiting and bone pain were
recognized as an oncologic emergency by 76% (n = 13) and 70% (n = 12) of the nurses
respectively (see Table 8). Sixty percent (n = 3) of physicians rated their response to
oncologic emergencies to be less than 5 minutes in 90% or more of cases, but only 24%
(n = 4) nurses reported that physicians respond in less than 5 minutes in 90% of the cases
(see Table 8). At the SPMC, 94% (n = 16) nurses reported that they are able to triage
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patients in less than 30 minutes, 100% (n = 5) physicians reported giving empiric
antibiotics upon suspicion of infection, and 80% (n = 9) of pharmacist reported no
knowledge of expedited antibiotic prescriptions in case of oncologic emergencies (see
Table 8). Antibiotics are reported to be available at least 90% of the time by 47% (n = 8)
nurses, 40% (n = 2) physicians and 73% (n = 8) pharmacists while reported medical
supplies ranged among nurses and physicians from as low as 0% for splints to as high as
100% for alcohol sanitizers (see Table 9).
Discussion
In this study, we found that patients‟ status, new or established, and referred or
non-referred, was the only predictor of AWT for patients admitted to the CCBDU unit of
the SPMC. This finding may be in part attributed to the study design in that new patients
may have been diagnosed with cancer during the visit to SPMC. Since caregivers were
unaware of the seriousness of their child‟s condition these caregivers may have
considered the symptom of fever to be due to a minor episode of illness. This may have
resulted in an increased AWT for these patients.
In the Philippines, as in other resource-poor countries (Ribeiro et al., 2008),
barriers to seeking care exist. Health care utilization models have identified access,
cultural factors, and social network as the most important determinants associated with
the healthcare seeking process (Andersen, 1995). Healthcare seeking by caregivers of
pediatric cancer patients in the Philippines is complex, and is affected by their learned
cultural and social conceptualization of health (McCray, 2004; Richards, Reid, & Watt,
2002) as well as their economic and social resources (Gordon, Flores, Heath). In the
Philippines, traditional medicine that includes faith healing and herbal medicine practiced
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by traditional healers or „hilots‟ is still a culturally accepted treatment option. This is
especially true in rural areas where modern healthcare facilities are sparse (LaVela,
Smith, Weaver, & Miskevics, 2004) and where distance and lack of transportation
(Flores et al., 1998) can make modern health care services difficult to reach. With 80% of
patients admitted to the CCBDU living in rural Mindanao (Eden, 2011) such cultural and
economic considerations may be possible reasons why AWT of new patients is more than
twice that of established patients.
Referred patients who are treated at the SPMC also have a significantly longer
AWT than non-referred patients. These patients may experience economic hardship after
their private insurance coverage has been depleted by private physicians and healthcare
institutions causing a delay in their time of arrival for subsequent treatment at the SPMC
upon referral. In the Philippines, 32% of its population lives below the poverty line (CIA,
2009). As a government supported tertiary care facility, the SPMC primarily serves the
lower socio-economic segment of the population living on the island of Mindanao. This
is evident as more than half of the parents report a household income of less than 3,000
pesos, 6% report no residential electricity and 24% rent or live with extended family.
Also 34% of the patients in the study population treated at the SPMC have three or more
siblings. Even though our analyses did not find an association, the economic cost
associated with childcare (Heath et al., 2006) may prolong AWT since only those
caregivers with existing family support and/or a social network (Gordon, Scuffham,
Hayes, & Newman, 2007) may be able to put off other family responsibilities (Fortner et
al., 2004; McCray, 2004) to bring their sick child to the hospital. In addition, while our
findings did not find an association with travel distance to the hospital, the shorter wait-
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time for known/established patients may be attributed to the availability of „House of
Hope‟ as an alternative residence for families living far from the SPMC. This facility is
located within walking distance of SPMC and allows 94% of the nurses employed by the
CCBDU to triage these patients within 30 minutes. Fast triage results in a shorter waittime for known patients and may in turn effectively shorten LOS as shown by established
patients being discharged two times faster than new patients. In our study, AWT is a
significant predictor of ICU admission suggesting that patients may be in more
deteriorated state of health upon receiving the first dose of antibiotic.
Family income was a significant predictor of „institutional‟ wait-time. Poor
patients waited on average 55% longer for that first dose of antibiotic than patients of
high income households. In the Philippines, PhilHealth is a national health insurance
program for all Philippine citizens. Poor patients, who have no insurance coverage, are
enrolled in PhilHealth upon arrival to the SPMC guaranteeing reimbursement for care
rendered to the institution. Indigent Philippine citizens who cannot pay the annual 1,200
pesos for health insurance coverage are covered by a special provision as part of this
social insurance program. Coverage limits however exist, and are expressed in volumes
of services such as 45 days of inpatient admission per household per year. Patients
exceeding these limits have to find qualifying locally funded state aid. In this study
referred patients were not unlike new patients in that they were also economically
disadvantaged, since their private health insurance coverage had been depleted at other
healthcare facilities, before being referred to the SPMC for treatment. At the SPMC,
patients‟ medication and medical supplies have to be purchased and retrieved by the
patient or the patient‟s family, either at the in-house pharmacy or at an external
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pharmacy, and brought back to the nurse‟s station for administration. Medications are
purchased with cash or the pharmacy bills PhilHealth. This administrative process may
contribute to the longer „institutional‟ wait-time for poor patients since income and
insurance coverage are associated with each other in this study population (χ2, (df = 6) =
27.95, p < .001).
LOS is also associated with socio-economic status; patients with parents who
have more than 12 years of formal education were discharged from the hospital twice as
fast as patients with parents of 8 years or less of formal education. At the SPMC, more
than 50% of caregivers of cancer patients had less than 12 years of education. Parental
education is associated with income, and subsequently, with the ability to pay for the
necessary medical care. Because most patients with low income had to be enrolled into
PhilHealth to cover the required medication, AWT may be prolonged for these patients.
While our study did not find an association between AWT and LOS, study findings
indicate that for every one day increase in AWT the odds to be admitted to ICU increased
by 12%. This suggests that patients were critically ill upon arrival to the hospital and very
sick patients with bacteremia/sepsis have 4 times the odds to be hospitalized in excess of
5 days as compared to patients without bacteremia/ sepsis (OR = 4.08, 95% CI:
3.66,4.43, p < .0001) (Basu, Fernandez, Fisher, Asselin, & Lyman, 2005).
To minimize the interval of AWT, effective communication between caregiver
and provider is important (Williams, Davis, Parker, & Weiss, 2002). In a prospective
cohort study of 251 patients conducted in El Salvador, Gavidia found that mothers with
low literacy waited longer to decide to seek care upon recognition of fever which
increased the odds for sepsis three fold in these pediatric cancer patients (OR = 3.06, 95%
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CI: 1.09,8.63; p = .034) (Gavidia et al., 2012). For established patients, therefore, who
are severely neutropenic, AWT can be minimized if caregivers understand the treatment
of their child and recognize signs and symptoms of infection, because immunesuppressed patients experienced six times the odds to be admitted to ICU as compared to
patients who have an ANC count of 500/µL or higher. Especially young inarticulate
children with cancer depend on the decision making ability of their caregiver. In our
study institutional wait-time decreases 6% for every yearly increase in the age of the
patient treated at the CCBDU. This suggests that older children may be better able to
communicate their state of health to their caregivers.
In addition, because symptoms of infection may not be overtly life threatening,
as for instance bleeding, it is possible that providers may not recognize the severity of the
situation (Dellinger et al., 2008; Freifeld et al., 2011; D. Hughes & Griffiths, 1997). For
that reason, an admission staff with a sufficient number of knowledgeable clinicians
(Needleman et al., 2002; West et al., 2004) and a triage mechanism that integrates various
specialties (Lau et al., 2010) is required to reduce the wait-time for the first critical dose
of antibiotic. Children who are undergoing chemotherapy and/or radiation should always
be considered high risk patients, especially if presenting with fever (Pizzo et al., 1991).
At the CCBDU, only 59% of the nurses recognized fever as an oncologic emergency by
contacting the physician on call in less than 15 minutes, and 24% of nurses reported that
the on-call physician responded most of the time in 5 minutes or less. Inadequate staffing
delays the prescription orders for antibiotic therapy for febrile cancer patients (Iregui et
al., 2002) and can lead to unnecessary deaths and longer hospitalizations through
suboptimal human resource allocation in form of low physician staffing patterns to care
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for critically ill patients in the ICU (Needleman et al., 2002; Pronovost, Marsteller, &
Goeschel, 2011). Institutional efficiency (Feachem, Sekhri, & White, 2002; Rechel,
Wright, Barlow, & McKee, 2010) as reflected in the hospital‟s capacity to process
patients quickly and cost-effectively, is an important factor in the delivery of timely
antibiotic therapy (Pines, Hollander, Localio, & Metlay, 2006). In the Philippines, as in
other resource-poor countries, institutional inadequacies also affect the availability of
necessary medical supplies (Ribeiro et al., 2008) which may delineate receipt of
healthcare based on the provider‟s perception of urgency. For example, patients who
appear to be critically ill may receive preferential treatment (Dixon-Woods et al., 2006;
D. Hughes & Griffiths, 1997). At the SPMC, we found that the perception of availability
of antimicrobials varied widely among healthcare providers. Forty-nine percent of
nurses, 40% of physicians and 73% of pharmacists found antibiotics to be available most
of the time. This discrepancy may indicate not only a lack of communication among
healthcare providers, but also a lack of coordination between departments at the SPMC as
it relates to the procurement of necessary medical supplies.
Study Limitations
As with any retrospective study information bias may affect the validity of the
study. Since these data were collected from existing medical records, we were unable to
verify them with the patient or the healthcare provider. Also, since onset of signs and
symptoms are self-reported by the patients‟ caregivers, wait time may be misclassified.
In addition to potential misclassification, missing data was also a limitation.
To retain participants in the multivariable model, those with missing insurance status,
parental education, number of siblings and family income were coded as “Unknown”.

19

The unknown category was a statistically significant predictor of institutional antibiotic
wait-time and LOS. Possible explanations for this finding may be population related or
process related. Missing data may be a result of language barriers, literacy levels, or
comfort level in revealing personal information like income. Alternatively, missing data
may be a result of the time and place of patient admission. Those admitted at night or on
weekends when staffing is limited may be more likely to be missing data. Another
possible explanation is that severe patients are rushed through the triage process and are
therefore more likely to be missing data.
Because the study population treated at the SPMC is a convenience sample that
includes a large number of socio-economically disadvantaged patients, this study may not
be representative of the overall pediatric cancer population of the Philippines. Another
limitation is the small sample size that may have limited our power to detect some
predictors of AWT. Additionally, the small number of deaths occurring during the six
month interval may not be accurate. Since study eligibility required a first dose of
antibiotic, some patients may have died before antibiotic therapy was administered and
were therefore not included in this study. Finally, because of the small number of deaths
occurring during the study, we were unable to study death as an outcome.
This study underlines the urgency for identifying predictors of wait-time in
developing countries. Health care access and health care delivery determine the time
elapsed before the first dose of antibiotic is given. Interventions aimed at reducing that
time to the recommended window of one-hour or less increases the patient‟s chance of
survival, reduces inpatient days and ICU admissions.
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Conclusions
Patients admitted to this pediatric oncology unit wait much longer than the
optimal one-hour window for antibiotic treatment. This long wait-time increases their risk
for infection progression and consequently longer hospital stay and/or ICU admission.
These results underline the importance of a shorter wait-time to antibiotic treatment for
febrile neutropenic patients.
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Appendix A

Table 1
Patient Characteristics
Patients, n = 97
Sex
Male
Female
Age in years
Mean age ±SD
Median (range)
Patient status
Known
Yes, established patient
No, new patient
Referred
Yes
No
Diagnosis
ALL, AML & Lymphomas
Other Tumors
Insurance coverage
Yes
No
Unknown
House ownership
Yes
No
Unknown
Residential electricity
Yes
No
Unknown
Family income
Unknown
Poor
Medium
High
Family support
Yes
No
Parental education
Unknown
> 12years
9 - 12years
≤ 8years

n

(%)

52
45

(54)
(46)

6.78
4.90

± 4.62
(0.04 - 17.83)

72
25

(74)
(26)

24
73

(25)
(75)

59
38

(61)
(39)

68
15
14

(70)
(16)
(14)

35
23
39

(36)
(24)
(40)

43
6
48

(44)
(6)
(49)

13
51
25
8

(13)
(53)
(26)
(8)

40
57

(41)
(59)

25
22
36
14

(26)
(23)
(37
(14)
(Table continues)
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Table 1(continued)
Patient Characteristics
Patient, n = 97
n (%)
Number of siblings
Unknown
19 (20)
>2
33 (34)
≤2
45 (46)
ANC
Unknown
12 (12)
≤ 500
26 (27)
> 500
59 (61)
Time to hospital (hours)†
Mean ± SD
2.49 ± 2.14
Median (range)
1.00 (0 - 8.00)
Transportation cost (pesos)†
Mean ± SD
156.46 ± 172.38
Median (range)
86.0 (8.00 - 700.00)
AWTa (days)
Mean ± SD
3.98 ± 4.67
Median (range)
2.38 (0 - 28.08)
Accessb (days)
Mean ± SD
3.29 ± 4.82
Median (range)
2.00 (0 - 28.00)
Institutional c (days)
Mean ± SD
0.84 ± 0.91
Median (range)
0.63 (0 - 4.46)
ICU-admission
Yes
17 (18)
No
80 (82)
Deaths
Yes
4 (4)
No
93 (96)
LOS** (days)
Mean ± SD
13.3 ± 10.19
Median (range)
11.66 (0.36 - 40.29)
a
b
8 patients were missing AWT; 6 patients were missing
c
access wait-time; 2 patients were missing institutional
wait-time. Data are presented as n and percent, † or mean,
standard deviation, median and range. **Those that died
were not included in the determination of LOS. Because
of rounding total percentages may not add up to 100%.
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Table 2
Determinants of AWT (in Days)
Diagnosis
ALL AML & Lymphomas
Other tumors
Patient status
Known
Yes
No
Referred
Yes
No
Medical insurance
Unknown
Yes
No
Residential electricity
Yes
No
House ownership
Yes
No
Family income
Unknown
Poor
Medium
High
Family support
Family
Other
Number of siblings
Unknown
>2
≤2
Parental education (years)
Unknown
> 12
9 - 12
≤8
ICU-admission
Yes
No
ANC
Unknown
≤ 500
> 500

M
4.41
3.22

SD
5.37
2.98

Median (Range)
2.46 (0.13-28.08)
2.17 (0-14.75)

t-statistic (df)
1.34 (87.00)
Reference

p
0.182

2.97
6.89

2.83
7.17

2.00 (0-15.04)
4.17 (0.29-28.08)

-2.55 (24.43)
Reference

0.018

5.73
3.41

5.28
4.34

4.17 (0.29-21.95)
2.04 (0-28.08)

2.06 (87)
Reference

0.042

4.08
3.82
4.60

3.70
4.32
6.86

3.06 (0.29-14.08)
2.25 (0-21.96)
2.81 (1.21-28.08)

-0.25 (19.98)
-0.41 (15.44)
Reference

0.806
0.688

3.51
2.49

4.46
1.68

1.88 (0-21.96)
2.08 (1.21-5.29)

0.50 (43)
Reference

0.617

2.95
4.06

2.84
5.30

1.79 (0-14.75)
2.17 (0.08-21.96)

-0.88 (27.65)
Reference

0.388

5.02
3.69
3.87
4.55

3.94
4.96
4.51
5.28

3.88 (0.29-14.08
2.25 (0-28.08)
2.00 (0.08-15.04)
2.42 (1.38-13.88)

0.21 (16)
-0.37 (50)
-0.30 (27)
Reference

0.839
0.717
0.767

3.41
4.30

4.52
4.76

2.15 (0-21.96)
2.58 (0.08-28.08)

-0.86 (87)
Reference

0.392

3.52
3.89
4.26

3.15
4.43
5.44

2.96 (0.29-14.08)
1.71 (0-15.04)
2.38 (0.08-28.08)

-0.66 (54.93)
-0.30 (68)
Reference

0.511
0.762

4.29
4.24
3.23
4.96

3.68
5.38
3.09
7.78

3.88 (0.29-14.75)
2.35 (0.13-21.96)
1.96 (0-15.04)
2.25 (0.08-28.08)

-0.30 (15.10)
-0.32 (31)
-1.10 (44)
Reference

0.772
0.753
0.279

5.90
3.53

5.90
4.25

3.88 (0-21.96)
2.21 (0.08-28.08)

1.91 (87)
Reference

0.060

2.80
4.35
3.99

1.84
5.14
4.89

2.46 (0.29-7.08)
2.79 (0.13-21.96)
2.17 (0-28.08)

0.171
0.657

Time to hospital (hours)
Transportation cost (pesos)

2.49
156.46

2.14
172.37

1.00 (0-8.00)
86.00 (8.00-700.00)

-1.39 (48.35)
0.45 (75)
Reference
Pearson r
0.033
0.001
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p
0.776
0.991

Table 3
Determinants Associated with AWT
Variables

AWT
Multivariate1 (n = 89)
HR (95% CI)
p

Bivariate
HR (95% CI)
0.76 (0.50,1.16)
Reference

Diagnosis
p
ALL,AML & Lymphoma
0.200
Other Tumors
Family income
Unknown
0.68 (0.28,1.66)
0.396
Poor
0.97 (0.41,2.63)
0.950
Medium
1.04 (0.71,1.68)
0.939
High
Reference
Sex
Male
1.00 (0.71,1.68)
0.676
Female
Reference
Patient status
Known
Yes
2.17 (1.30,3.60)
2.17 (1.29,3.64)
0.003
0.003
No
Reference
Insurance coverage
Unknown
1.02 (0.47,2.22)
0.956
Yes
1.22 (0.62,2.39)
0.557
No
Reference
Family support
Family
1.24 (0.77,2.01)
0.378
Other
Reference
ANC
Unknown
0.96 (0.53,1.75)
0.903
≤ 500
0.84 (0.52,1.36)
0.489
> 500
Reference
Age*
1.00 (0.95,1.04)
0.846
Number of siblings
Unknown
0.85 (0.49,1.49)
0.316
>2
0.91 (0.54,1.52)
0.711
≤2
Reference
Parental education
Unknown
0.93 (0.41,2.10)
0.869
> 12years
1.22 (0.50,2.95)
0.660
9 - 12years
1.32 (0.58,2.99)
0.510
≤ 8years
Reference
Admission day
Weekend
0.99 (0.59,1.65)
0.973
Weekdays
Reference
1
Sample size of multivariate analysis; the possible confounders „house ownership, „residential electricity‟,
time to hospital and transportation cost‟ were found not to be significant in the multivariate analyses.
*Corresponds to increase in hazard per 1 year change in variable. Bolded values indicate significance at p <
.05.
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Table 4
Determinants of Access and Institutional Wait-times
Accessa

Variables
Diagnosis
ALL,AML &
Lymphoma
Other tumors
Family income
Unknown
Poor
Medium
High
Sex
Male
Female
Patient status
Known
Yes
No
Insurance coverage
Unknown
Yes
No
Family support
Family
Other
ANC
Unknown
≤ 500
> 500
Age*

Bivariate
HR (95% CI)
p
0.83 (0.59,1.17)
0.282

1

Multivariate (n = 91)
HR (95% CI)
p

Reference

Institutionalb
Bivariate
Multivariate2 (n = 95)
HR (95% CI)
p
HR (95% CI)
p
1.18 (0.77,1.80)
0.454
Reference

0.92 (0.44,1.92)
1.28 (0.63,2.60)
1.14 (0.56,2.32)
Reference

0.821
0.490
0.721

0.66 (0.29,1.47)
0.61 (0.28, 1.30)
0.85(0.39,1.86)
Reference

0.308
0.196
0.683

1.14 (0.80,1.62)
Reference

0.478

1.03 (0.69,1.52)
Reference

0.898

2.11 (1.35,3.32)
Reference

0.001

0.85 (0.51,1.42)
Reference

0.530

0.86 (0.44,1.68)
1.04 (0.58,1.88)
Reference

0.665
0.892

1.76 (0.73,4.26)
1.27 (0.63,2.57)
Reference

1.17 (0.80,1.72)
Reference

0.418

0.84 (0.49,1.41)
0.87 (0.59,1.27)
Reference
1.00 (0.96,1.04)

0.501
0.465

2.11 (1.35,3.32)

0.894
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0.001

0.36 (0.16,0.80)
0.45 (0.21,0.95)
0.79 (0.37,1.69)

0.012
0.037
0.547

0.212
0.503

3.83 (1.39,10.57)
1.29 (0.60,2.76)

0.010
0.510

0.78 (0.52,1.16)
Reference

0.218

0.65 (0.42,1.02)

0.060

1.01 (0.53,1.90)
1.01 (0.69,1.48)
Reference
1.03 (0.98,1.07)

0.98
0.942
0.265

1.06 (1.01,1.11)
0.021
(Table continues)

Table 4 (continued)
Determinants of Access and Institutional Wait-times
Variables

Accessa
1

Institutionalb
Bivariate
Multivariate2 (n = 95)
HR (95% CI)
p
HR (95% CI)
p
0.71 (0.40,1.29)
0.262
1.08 (0.70,1.67)
0.732
Reference

Bivariate
Multvariate (n = 91)
Number of siblings
HR (95% CI)
p
HR (95% CI)
p
Unknown
0.94 (0.60,1.47)
0.787
>2
0.99 (0.65,1.51)
0.973
≤2
Reference
Parental education
Unknown
0.95 (0.48,1.88)
0.880
0.66 (0.24,1.76)
0.405
0.23 (0.08,0.61)
> 12 years
1.14 (0.55,2.35)
0.720
0.83 (0.32,2.17)
0.707
0.46 (0.17,1.22)
9 - 12 years
1.15 (0.59,2.25)
0.681
0.88 (0.34,2.31)
0.794
0.53 (0.21,1.32)
≤ 8 years
Reference
Reference
Admission day
Weekend
1.06 (0.69,1.63)
0.785
0.75 (0.49,1.16)
0.197
Weekdays
Reference
Reference
a
Access is the length of time from onset of sign and symptoms to hospital admission. bInstitutional is the length of time from hospital admission
to first dose of antibiotic given. *Corresponds to increase in hazard per 1 unit change in variable. Bolded values indicate significance at p < .05.
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0.003
0.118
0.176

Table 5
Determinants of Length of Hospital Stay
Variables
Bivariate
Multivariate1 (n = 93)
Diagnosis
HR (95%CI)
p
HR (95%CI)
p
ALL, AML & Lymphoma 1.67 (1.09,2.55) 0.017
Other tumors
Reference
Family income
Unknown
2.66 (1.22,5.79) 0.014
3.46 (1.37,8.74)
0.009
Poor
1.75 (0.53,2.17) 0.839
1.50 (0.58,3.82)
0.401
Medium
0.62 (0.29,1.33) 0.218
0.79 (0.30,2.08)
0.636
High
Reference
Sex
Male
0.84 (0.55,1.27) 0.410
Female
Reference
Patient status
Known
Yes
1.54 (1.08,2.20) 0.017
2.07 (1.40,3.07)
< 0.001
No
Reference
Insurance coverage
Unknown
1.17 (0.68,2.00) 0.575
Yes
1.35 (0.84,2.18) 0.214
No
Reference
ANC
Unknown
1.58 (0.89,2.78) 0.116
≤ 500
1.47 (0.93,2.32) 0.104
> 500
Reference
Family support
Yes
1.06 (0.68,2.00) 0.801
No
Reference
Age*
1.02 (0.84,2.18) 0.370
Parental education
Unknown
0.80 (0.48,1.35) 0.405
1.02 (0.58,1.80)
0.940
> 12years
3.22 (1.54,6.71)
2.08 (1.15,3.75) 0.015
0.002
9 - 12years
1.71 (0.61,1.70) 0.549
1.27 (0.67,2.43)
0.462
≤ 8years
Reference
AWT
0.99 (0.96,1.06) 0.383
1
Sample size of multivariate analysis. Analyses include only those alive at discharge. *Corresponds
to increase in hazard per 1 year change in variable. Bolded values indicate significance at p < .05.
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Table 6
Determinants of ICU Admission
Variables
Diagnosis
ALL, AML & Lymphoma
Other tumors
Family income
Unknown
Poor
Medium
High
Sex
Male
Female
Patient
Known
Yes
No
Insurance coverage
Unknown
Yes
No
ANC
Unknown
≤ 500
> 500
Family support
Family
Other
Age*
Number of siblings
Unknown
>2
≤2
Parental education
Unknown
> 12years
9 - 12years
≤ 8years
AWT (days)

Bivariate
OR (95% CI)
6.14 (1.32,28.62)
Reference

p
0.021

Multivariate (n = 89)
OR (95% CI)
p

1.27 (0.10,16.81)
1.70 (0.19,15.51)
1.33 (0.13,14.01)
Reference
1.74 (0.59,5.17)
Reference

0.316

0.42 (0.14,1.25)
Reference

0.117

1.60 (0.29,8.90)
0.69 (0.17,2.89)
Reference

0.591
0.612

9.82 (2.12,45.45)
6.11 (1.64,22.71)
Reference

0.004
0.007

1.00 (0.34,2.89)
Reference
1.06 (0.95,1.18)

1.000

1.73 (0.43,7.02)
1.75 (0.53,5.80)
Reference

0.441
0.360

1.16 (0.24,5.58)
0.18 (0.02,1.88)
0.89 (0.19,4.05)

0.855
0.150
0.875

1.09 (0.99,1.21)

0.081

11.40 (2.26,57.52)
6.02 (1.50,24.11)

0.003
0.011

0.299

1.12 (1.00,1.25)

0.043

*Corresponds to increase in hazard per 1 year change in variable. Bolded values indicate significance at p < .05.
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Table 7
Demographics of Healthcare Providers (n = 36)
Healthcare Provider Survey
Sex
Male
Female
Occupation
Nurse
Physician
Pharmacist
Lab. Technician
Employment (years)
All employees
Mean ± SD
Median (range)
Nurses
Mean ± SD
Median (range)
Physicians
Mean ± SD
Median (range)
Pharmacists
Mean ± SD
Median (range)
Technicians
Mean ± SD
Median (range)
Workload (patients/day)
Nurses
Mean ± SD
Median (range)
Physicians
Mean ± SD
Median (range)
Pharmacists
Mean ± SD
Median (range)
Technicians
Mean ± SD
Median (range)

n
5
31

(%)
(14)
(86)

17
5
11
3

(47)
(14)
(31)
(8)

4.18
1.8

± 7.19
(0.006 - 39.0)

1.43
1

± 1.29
(0.006 - 4.0)

2.92
2

± 3.46
(0.583 - 9.0)

5.00
3

± 5.29
(0.667 - 18.0)

18.67
14

± 18.44
(3.0 - 39.0)

20
20

±4
(6 - 25)

31
25

± 12
(20 - 50)

217
250
20
20

34

± 80
(100 - 300)
±0
NA

Table 8
Survey of Healthcare Providers: Standard of Care Practices1
Physicians, n = 5
Respond to fever in < 5 minutes
Respond to fever in 5-30 minutes
Respond to fever in 30-60 minutes
Empiric ABX prescription
Follow protocol
Select ABX from formulary
Select ABX according to Sanford guide
Select ABX according to best judgment

Know new treatment guidelines
Participate in infection training
Locate and refer to infection care manual
Technicians, n = 3
Preliminary results reported in < 24 hours
Preliminary results reported in 24- 48 hours
Preliminary results reported in > 48 hours
Pharmacy, n=11
Antibiotic prescriptions are marked „stat‟
„Stat‟ prescriptions are delivered by nurse
Nurses, n = 17
Clinical Events: MD contacted in cases of:
Bleeding
Unstable vital signs
Vomiting
Bone pain
Fever >38o C
Nausea
Pallor
Fatigue
Weight loss
Coughing

Triage patients within 30 minutes
Know new treatment guidelines
Participate in infection training
Locate and refer to infection care manual

Most of the time1
n (%)
3 (60)
2 (40)

Sometimes2
n (%)
2 (40)
1 (20)
2 (40)

5 (100)
5 (100)
4 (80)
4 (80)
4 (80)

1 (20)
1 (20)
1 (20)

Yes
4 (80)
2 (40)
4 (80)

No
1 (20)
3 (60)
1 (20)

Most of the time
1 (33)
2 (67)

7 (78)

< 15 Minutes
17 (100)
17 (100)
13 (77)
12 (71)
10 (59)
10 (59)
10 (59)
7 (41)
5 (29)
4 (24)
Yes
16 (94)
15 (88)
14 (82)
14 (82)

Sometimes
2 (67)
1 (33)
3 (100)
1 (10)
1 (11)

15 - 30 Min.

4 (24)
3 (18)
7 (41)
6 (35)
4 (24)
6 (35)
3 (18)
8 (47)

Rarely3
n (%)

Never
n (%)

2 (40)
1 (20)

2 (40)

Rarely

1 (10)

30 - 60 Min.

9 (80)
1 (11)

60 Min

2 (12)
1 (6)
3 (18)
2 (12)
5 (29)

2 (12)
4 (24)
5 (29)

No
1 (6)
2 (12)
3 (18)
3 (18)

Nurses‟ perception of MD response
Most of the time
Sometimes
Rarely
On-call MD responds in < 5 minutes
4 (24)
11 (65)
2 (12)
On- call MD responds in 5 - 30 minutes
7 (42)
10 (59)
On- call MD responds in 30 - 60 minutes
8 (47)
9 (53)
1
Are presented as % and n of non-missing values. 2Most of the Time signifies greater than 90% of the time.
3
Sometimes signifies less than 50% of the time. 4Rarely signifies less than 10% of the time.
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Never

Never

Table 9
Survey of Healthcare Providers: Availability of Antibiotics and Medical Supplies1
Pharmacy, n = 11
ABX* available at pharmacy
ABX had to be substituted
Physicians, n = 5
ABX available at pharmacy
ABX had to be substituted
Needle available
IV fluids available
Catheters available
Tapes available
Gloves available
Gauze available
Splints available
Alcohol sanitizers available
Culture plates available
Glassware available
Tourniquets available
Other equipment available
Nurses, n = 17
ABX available at pharmacy
ABX had to be substituted
Needles available
IV fluids available
Catheters available
Tapes available
Gloves available
Gauze available
Splints available
Alcohol sanitizers available
Culture plates available
Glassware available
Tourniquets available
Other equipment
Technicians, n = 3
Supplies for culture & sensitivity
analysis available
Reagents available

Most of the time1
n (%)
8 (73)
1 (9)

Sometimes 2
n (%)
3 (27)
8 (73)

Rarely3
n (%)

Never
n (%)

2 (18)

2 (40)
3 (60)
4 (80)
3 (60)
3 (60)
5 (100)
5 (100)
5 (100)
1 (20)
5 (100)
5 (100)
5 (100)
2 (40)
5 (100)

2 (40)
2 (40)
1 (20)
2 (40)
2 (40)

1 (20)

2 (40)

2 (40)

8 (47)
5 (29)
15 (88)
13 (77)
10 (59)
15 (88)
13 (77)
15 (88)

9 (53)
11 (65)
2 (12)
3 (18)
3 (18)
2 (12)
4 (24)
2 (12)

3 (60)

1 (6)
1 (6)
3 (18)

1 (6)

17 (100)
17 (100)
6 (35)
13 (77)
10 (59)
9 (53)

10 (59)
3 (18)
2 (12)
7 (41)

1 (6)
1 (6)
4 (24)
1 (6)

1 (6)

3 (100)
3 (100)

1

Are presented as % and n of non-missing values. 2Most of the Time signifies greater than 90% of the time;
3
Sometimes signifies less than 50% of the time; 4Rarely signifies less than 10% of the time; *ABX: antibiotic.
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Appendix D
From: Alvin Concha [mailto:alvinconcha@yahoo.com]
Sent: Monday, August 22, 2011 3:06 AM
To: mae dolendo; Kirby, Jeannette
Cc: Guimera, Don G; 'mae dolendo'; 'Czarina Mae Castillo'; Lin Alba; veronica deniega; Maria
Luisa Nuque-Lope
Subject: Research Protocol Approval - Dr Mae Concepcion Dolendo
Re: Application for IRB approval of the research protocol entitled “Evaluation of the length of time
from onset of signs and symptoms of infection to the start of antibiotic administration in pediatric
cancer patients in Davao City, Philippines"
Dear Dr Mae Concepcion Dolendo,
The Region XI Integrated Research Board - Cluster Ethics Review Committee (RXIIRB CERC)
hereby grants you the approval to conduct your study. You may now print a copy of the approved
(latest) version of the protocol and submit them to the Hospital Research Committee Office at
Southern Philippines Medical Center (SPMC). Please date the protocol version "18 August 2011."
Please also submit to CERC a statement from Pediatrics Oncology Section that Ms Czarina Mae
Castillo-Deluao will be excused from her responsibilities as Pediatrics Oncology nurse while she
performs her research tasks as defined in the latest protocol version.
You will soon receive the original copy of the Certificate of Approval issued by the CERC. We will
notify you once the certificate is ready for pick up. Please prepare to show the certificate to
anyone involved with your study whenever you are asked for it.
You may now start your study. Please employ all measures in order to adhere to the methods
described in the approved protocol. You are required to inform the CERC in writing during the
following occasions:
1. any protocol changes (for CERC repeat review and approval)
2. any protocol deviations
3. any protocol violations
4. existence of new information that may affect the safety or privacy of the participants of the
original data gathering process
Please be reminded, as well, that the CERC may conduct spot checks in order to monitor the
study’s compliance with ethics requirements.
After completion of the study, you are also required to submit to the CERC one hardcopy and a
softcopy (in CD) of the full research report, journal articles, books and any other written or
electronic documents or publications generated by this research project.
We wish you a successful and worthwhile research experience!
Sincerely yours,
-ALVIN S. CONCHA, MD
Chair, Cluster Ethics Review Committee
Region XI Integrated Research Board (RXIIRB)
Hospital Research Office
Family Medicine Complex, JICA Building
Southern Philippines Medical Center
Mobile +639174004945; +639232753749
Phone +63822272731 local 4607
Telefax +63822217029 (SPMC); +63844004597 (DRH)
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